-
"2021 China High Net Worth People's Health Investment White Paper" released
Time of Update: 2022-01-08
China Merchants Cigna Life's break-through strategy is to find out the positioning of insurance services in health management and wealth inheritance, starting from the needs and pain points of different high-net-worth individuals, and truly let the protection play a role .
-
Biogynocinagen Sodium was included in the new medical insurance drug list, and it was successfully implemented on the first day of landing
Time of Update: 2022-01-08
The low accessibility of rare disease drugs enrolled in the insurance "break-through" helps improve the level of diagnosis and treatment of SMAAs the doctor who prescribed the first batch of prescriptions for Nocinnasheng Sodium Injection after entering the medical insurance catalogue, Professor Zhong Jianmin, Department of Neurology , Jiangxi Children’s Hospital, said : “SMA is currently the number one genetic disease killer for infants under two years old.
-
The first domestic phase I clinical study of anti-ST2 antibody completed the first group of subjects enrolled
Time of Update: 2022-01-08
62em; font-family:"Arial"; color:black; margin:0in; } </>Shanghai, December 29, 2021/PRNewswire/ - Maiwei Bio, an innovative biopharmaceutical company with a full industry chain layout, announced that its anti-ST2 antibody (R&D code: 9MW1911) Phase I clinical study has completed the first set in China Healthy subjects were included in the group .
-
PacBio launches the new coronavirus whole-genome sequencing solution, without fear of all kinds of mutations of the new coronavirus
Time of Update: 2022-01-08
On December 28, PacBio announced that its HiFiViral SARS-CoV-2 solution had successfully captured the new mutant strain Omicron and completed Omicron whole genome sequencing .
Some users have verified the effectiveness of the PacBio HiFiViral SARS-CoV-2 kit and confirmed that it performs well on the corresponding Omicron strain .
-
Faith Medicine completes China's first registered clinical intravenous administration of AAV gene therapy for hemophilia B
Time of Update: 2022-01-07
, a wholly-owned subsidiary of Faith Pharmaceuticals (for the prevention of hemophilia B) The clinical trial of AAV gene therapy drug for bleeding in adult male patients successfully completed the administration of the first subject .
-
Abcam and Alamar Biosciences join hands to advance the understanding of the human proteome
Time of Update: 2022-01-07
62em; font-family:"Arial"; color:black; margin:0in; } </>Cambridge, UK, January 4, 2022/PRNewswire/ - Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in the field of life science reagents and tools , is committed to transforming the field of proteomics to achieve early tumors and other diseases Alamar Biosciences (Alamar), a testing platform company , today announced the establishment of a strategic partnership to jointly promote a better understanding of the human proteome .
-
Significant progress has been made in the research of Chinese scientists in response to Omi Keron
Time of Update: 2022-01-07
The joint team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Jimin Trust successfully analyzed the structure of the spike protein of Omi Keron mutant strain and the specific therapeutic antibody JMB2002 (Figure 2C).
-
Boaoxin Biological Appoints Dr. Xinliang Ye as Chief Strategy Officer and Head of Business Development in China
Time of Update: 2022-01-07
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.
Ye served as the vice president of CStone Pharmaceuticals (HKSE: 2616), responsible for the company's corporate strategy, capital markets and investor relations .
-
Researchers have developed miniature fiber optic therapy equipment, more effective cancer immunotherapy
Time of Update: 2022-01-06
Image: The microfiber device developed by the School of Engineering at Virginia Tech can make cancer immunotherapy more effective .
They developed a miniature optical fiber therapy device that can provide cancer immunotherapy antibodies and measure tumor impedance to monitor treatment.
-
The potential role of ibuprofen in the immunity of the elderly with respiratory syncytial virus
Time of Update: 2022-01-06
In contrast, young adult cotton rats can clear the virus quite effectively and produce an appropriate immune response to re-infection a month later, but ibuprofen has no effect .
Ibuprofen is only effective in elderly animals, and research results show that the drug improves the immune response by reducing inflammation associated with aging .
-
Blocking tau may help patients with ALS
Time of Update: 2022-01-06
can reverse the changes in mitochondrial shape and function caused by als," said Ghazaleh Sadri-Vakili, director of the Neuroepigenetics Laboratory at the Institute of Neurodegenerative Diseases, Massachusetts General Hospital .
-
Discovery of the microbiome helps save children’s hearing
Time of Update: 2022-01-06
Coleman said: “One-third to one-half of Aboriginal and Torres Strait Islander children will be affected by chronic middle ear infections, which far exceeds the 4% threshold of the World Health Organization that requires urgent public health action.
Upper Respiratory Tract Microbiome of Australian Aboriginal and Torres Strait Islander Children in Ear and Nose Health and Disease .
-
The plasma protein fibrinogen directly interacts with nerve cells, causing brain inflammation
Time of Update: 2022-01-06
David Lomadze, Professor of Surgery, Molecular Pharmacology, and Physiology at the Morsani School of Medicine at the University of South Florida Health (USF Health), studied how changes in the blood vessels caused by neuroinflammation impair cognition, including short-term memory .
-
Early adrenaline therapy helps recover from cardiac arrest
Time of Update: 2022-01-06
According to preliminary research that will be presented at the American Heart Association's Resuscitation Science Symposium (ReSS) in 2021, early adrenaline therapy during cardiac arrest is associated with better recovery compared to later treatment .
-
New symptoms can help doctors diagnose pancreatic cancer
Time of Update: 2022-01-06
The researchers hope that their findings can help general practitioners diagnose this disease earlier, especially when the patient has some seemingly non-specific symptoms, thereby improving survival .
-
A new vaccine is ready to go!
Time of Update: 2022-01-05
From 2019 to 2021, the international epidemic continues to spread . • In the face of the global epidemic, what are the problems that need to be solved urgently in the prevention and control of the ne
-
Penicillin can significantly reduce the development of rheumatic heart disease in children
Time of Update: 2022-01-05
The study, led by Murdoch Children’s Research Institute (MCRI), Cincinnati Children’s Hospital Medical Center, Uganda Heart Research Institute, and Washington Children’s National Hospital also shows that early screening is essential for preventing the progression and death of severe rheumatic heart disease in young children Important .
-
Colon cancer screening FIT is not applicable to emergency and inpatients
Time of Update: 2022-01-05
A clinical study by the Indiana University School of Medicine and the Regenstrief Institute examined the use of FIT (fecal immunochemical testing) in emergency and hospital patients, which looks for blood in the stool, which is a possible sign of colorectal cancer .
-
my country's special drugs for the treatment of COVID-19 are expected to be on the market soon
Time of Update: 2022-01-05
Among them, two effective neutralizing antibody drugs BRII-196 and BRII-198 jointly developed and screened by Tsinghua University, Shenzhen Third People's Hospital and Tengsheng Huachuang Medical Technology have participated in the treatment of more than 700 patients in China .
-
The world's first inhaled COVID-19 vaccine
Time of Update: 2022-01-05
No vaccinationPreviously, the new coronary pneumonia aerosol inhalation vaccine developed by Academician Chen Wei's team published clinical research data in the journal "Lancet Infectious Diseases".
This is the world's first public release of the clinical trial results of the new coronary pneumonia vaccine mucosal immunity .
